New antibiotic pouch aims to stop infections in heart device patients
NCT ID NCT06854081
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is tracking 100 adults who receive an EluPro antibiotic-eluting envelope during implantation of a heart device (like a pacemaker). The envelope slowly releases antibiotics to prevent infection. Researchers are monitoring complication rates in real-world use to see how safe and effective it is.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
EluPro Antibiotic-Eluting BioEnvelope (a mesh pouch that releases antibiotics around a heart device)
What this could lead to
If successful, this could show that the EluPro envelope helps prevent infections in people with implanted heart devices, leading to safer procedures.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the envelope works better than standard care. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ARRHYTHMIAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham & Women's Hospital
Boston, Massachusetts, 02115, United States
-
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, 19104, United States
-
Tallahassee Research Institute
Tallahassee, Florida, 32308, United States
-
UC San Diego Health
La Jolla, California, 92037, United States